Novo Nordisk A S NVO Ratios (2012-2017)

NYSE NVO
$38.89 -0.56 (-1.42%)
At close: Nov 19, 2026 · 4:00 PM EST
Reported Financials

Novo Nordisk A S Quarterly Ratios

Periods 7 quarters
Latest Sep 2017
Industry Template General

Novo Nordisk A S ratios data for the quarter ended Sep 2017. These financial ratios cover 7 quarters of results from Dec 2012 through Sep 2017, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2012 Dec2014 Dec2015 Dec2016 Mar2017 Jun2017 Sep2017
Profitability
Gross Margin 1,773.17%83.60%83.33%
EBT Margin 763.83%38.39%36.81%
EBIT Margin 36.14%68.11%37.72%
EBITDA Margin 110.11%71.97%41.52%
Operating Margin 36.14%68.11%37.72%
Net Margin 27.46%29.82%29.28%
FCF Margin 2.61%4.49%29.02%
Efficiency
Inventory AverageInventory Avg. 15,036.00M15,129.00M
Assets AverageAssets Avg. 73,699.50M84,430.50M20,865.50M20,381.50M
Equity AverageEquity Avg. 44,368.50M47,691.00M
Invested CapitalInvested Cap. 40,914.00M50,119.00M47,206.00M
Leverage & Solvency
Interest Coverage RatioInterest Cover 54.83107.4344.94
Debt Ratio -0.010.030.080.01
Times Interest Earned 54.83107.4344.94
Return Ratios
Return on Sales [ROS]ROS 36.14%68.11%37.72%
Return on Assets [ROA]ROA 57.61%

Novo Nordisk A S Ratios API

Pull Novo Nordisk A S's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVO&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY